References
- Tedder M, Spratt JA, Anstadt MP et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thoracic Surg. 1994; 57: 1044–50.
- McAdams HP, Rosado-de-Christenson M, Strollo DC, Patz EF. Pulmonary mucormycosis: radiologic findings in 32 cases. Am J Roentgenol 1997; 168: 1541–8.
- Rangel-Guerra RA, Martinez HR, Saenz C et al. Rhinocerebral and systemic mucormycosis: clinical experience with 36 cases. J Neurol Sci. 1996; 143: 19–30.
- Zapatero J, Flandes J, Ruiz-Zafra J et al. Bronchovascular mucormycosis: an urgent surgical problem. Eur J Cardiothorac Surg. 1995; 9: 286–8.
- Abraham P, Govil S, Srivastava VM, Ganesh A. Spontaneous regression of pulmonary mucormycosis. Postgrad Med J. 1995; 71: 632–4.
- Verdonck AK, Boelaert JR, Gordts BZ, Van Landuyt HW. Effect of ferrioxamine on the growth of Rhizopus. Mycoses 1993; 36: 9–12
- McNab A A, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch Ophtalmol. 1997; 115: 919–21.
- Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997; 98: 497–501.
- Maertens J, Boogaerts MA. Anti-infective strategies in neutropenic patients Acta Clin Belg. 1998; 53: 168–77.
- Ralph ED, Khazindar AM, Barber KR, Grant CW. Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains, determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves. Antimicrob Agents Chemother. 1991; 35: 188–91.
- Fisher EW, Toma A, Fisher PH, Cheesman AD. Rhinocerebral mucormycosis: use of liposomal amphotericin B. J Laryngol Otol. 1991; 105: 575–77.
- Raj P, Vella EJ, Bickerton RC. Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin - a case report. J Laryngol Otol. 1998; 112: 367–70.